The Short-Term Impact of Botulinum Neurotoxin-A on Muscle Morphology and Gait in Children with Spastic Cerebral Palsy

The Short-Term Impact of Botulinum Neurotoxin-A on Muscle Morphology and Gait in Children with Spastic Cerebral Palsy

Children with spastic cerebral palsy (SCP) are often treated with intramuscular Botulinum Neurotoxin type-A (BoNT-A). Recent studies demonstrated BoNT-A-induced muscle atrophy and variable effects on gait pathology. This group-matched controlled study in children with SCP compared changes in muscle...

Full description

Bibliographic Details
Main Authors: Nicky Peeters, Eirini Papageorgiou, Britta Hanssen, Nathalie De Beukelaer, Lauraine Staut, Marc Degelaen, Christine Van den Broeck, Patrick Calders, Hilde Feys, Anja Van Campenhout, Kaat Desloovere
Format: Article
Language:English
Published: MDPI AG 2022-09-01
Series:Toxins
Subjects:
botulinum neurotoxin type-A
spastic cerebral palsy
gait
ultrasound
muscle morphology
treatment
Online Access:https://www.mdpi.com/2072-6651/14/10/676

Internet

https://www.mdpi.com/2072-6651/14/10/676

Similar Items